|
1
|
Dittmar T, Nagler C, Schwitalla S, Reith
G, Niggemann B and Zänker KS: Recurrence cancer stem cells-made by
cell fusion? Med Hypotheses. 73:542–557. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang ZJ and Wechsler-Reya R: Hit'em where
they live: Targeting the cancer stem cell niche. Cancer Cell.
11:3–5. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen C, Xiang M, Nie C, Hu H, Ma Y and Wu
H: CD44 as a molecular marker to screen cancer stem cells in
hypopharyngeal cancer. Acta Otolaryngol. 133:1219–1226. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Misra S, Toole BP and Ghatak S: Hyaluronan
constitutively regulates activation of multiple receptor tyrosine
kinases in epithelial and carcinoma cells. J Biol Chem.
281:34936–34941. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ghatak S, Misra S and Toole BP: Hyaluronan
constitutively regulates ErbB2 phosphorylation and signaling
complex formation in carcinoma cells. J Biol Chem. 280:8875–8883.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim HR, Wheeler MA, Wilson CM, Iida J, Eng
D, Simpson MA, McCarthy JB and Bullard KM: Hyaluronan facilitates
invasion of colon carcinoma cells in vitro via interaction
with CD44. Cancer Res. 64:4569–4576. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Du L, Wang H, He L, Zhang J, Ni B, Wang X,
Jin H, Cahuzac N, Mehrpour M, Lu Y and Chen Q: CD44 is of
functional importance for colorectal cancer stem cells. Clin Cancer
Res. 14:6751–6760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones RJ, Barber JP, Vala MS, Collector
MI, Kaufmann SH, Ludeman SM, Colvin OM and Hilton J: Assessment of
aldehyde dehydrogenase in viable cells. Blood. 85:2742–2746.
1995.PubMed/NCBI
|
|
9
|
Armstrong L, Stojkovic M, Dimmick I, Ahmad
S, Stojkovic P, Hole N and Lako M: Phenotypic characterization of
murine primitive hematopoietic progenitor cells isolated on basis
of aldehyde dehydrogenase activity. Stem Cells. 22:1142–1151. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Storms RW, Green PD, Safford KM,
Niedzwiecki D, Cogle CR, Colvin OM, Chao NJ, Rice HE and Smith CA:
Distinct hematopoietic progenitor compartments are delineated by
the expression of aldehyde dehydrogenase and CD34. Blood.
106:95–102. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsui W, Huff CA, Wang Q, Malehorn MT,
Barber J, Tanhehco Y, Smith BD, Civin CI and Jones RJ:
Characterization of clonogenic multiple myeloma cells. Blood.
103:2332–2336. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pearce DJ, Taussig D, Simpson C, Allen K,
Rohatiner AZ, Lister TA and Bonnet D: Characterization of cells
with a high aldehyde dehydrogenase activity from cord blood and
acute myeloid leukemia samples. Stem Cells. 23:752–760. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Naumov GN, Bender E, Zurakowski D, Kang
SY, Sampson D, Flynn E, Watnick RS, Straume O, Akslen LA, Folkman J
and Almog N: A model of human tumor dormancy: An angiogenic switch
from the nonangiogenic phenotype. J Natl Cancer Inst. 98:316–325.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu Y and Zhu Z: Cell dormancy and tumor
refractory. Anticancer Agents Med Chem. 13:199–202. 2013.
View Article : Google Scholar
|
|
15
|
Quesnel B: Tumor dormancy: Long-term
survival in a hostile environment. Adv Exp Med Biol. 734:181–200.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wells A, Griffith L, Wells JZ and Taylor
DP: The dormancy dilemma: Quiescence versus balanced proliferation.
Cancer Res. 73:3811–3816. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kleffel S and Schatton T: Tumor dormancy
and cancer stem cells: Two sides of the same coin? Adv Exp Med
Biol. 734:145–179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duvillié B, Attali M, Aiello V, Quemeneur
E and Scharfmann R: Label-retaining cells in the rat pancreas:
Location and differentiation potential in vitro. Diabetes.
52:2035–2042. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Diermeier-Daucher S, Clarke ST, Hill D,
Vollmann-Zwerenz A, Bradford JA and Brockhoff G: Cell type specific
applicability of 5-ethynyl-2′-deoxyuridine (EdU) for dynamic
proliferation assessment in flow cytometry. Cytometry A.
75:535–546. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qian Y: Tumorigenic cancerstemcells,
methods of isolating and using the same. Google Patents,
US20110206735. 2011.
|
|
21
|
Wang S, Kanojia D, Lo P, Chandrashekaran
V, Duan X, Berger FG, Wang Q and Hexin C: Enrichment and selective
targeting of cancer stem cells in colorectal cancer cell lines. Hum
Genet Embryol. S2:0062012.
|
|
22
|
Deleyrolle LP, Harding A, Cato K,
Siebzehnrubl FA, Rahman M, Azari H, Olson S, Gabrielli B, Osborne
G, Vescovi A and Reynolds BA: Evidence for label-retaining
tumour-initiating cells in human glioblastoma. Brain.
134:1331–1343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rao GH, Liu HM, Li BW, Hao JJ, Yang YL,
Wang MR, Wang XH, Wang J, Jin HJ, Du L and Chen Q: Establishment of
a human colorectal cancer cell line P6C with stem cell properties
and resistance to chemotherapeutic drugs. Acta Pharmacol Sin.
36:793–804. 2013. View Article : Google Scholar
|
|
24
|
Miyoshi N, Ishii H, Nagai K, Hoshino H,
Mimori K, Tanaka F, Nagano H, Sekimoto M, Doki Y and Mori M:
Defined factors induce reprogramming of gastrointestinal cancer
cells. Proc Natl Acad Sci USA. 107:40–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smith SM and Cai L: Cell specific CD44
expression in breast cancer requires the interaction of AP-1 and
NFκB with a novel cis-element. PLoS One. 7:e508672012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang SJ, Wong G, de Heer AM, Xia W and
Bourguignon LY: CD44 variant isoforms in head and neck squamous
cell carcinoma progression. Laryngoscope. 119:1518–1530. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ricardo S, Vieira AF, Gerhard R, Leitão D,
Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F and Paredes
J: Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression
distribution within intrinsic molecular subtype. J Clin Pathol.
64:937–946. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Buck SB, Bradford J, Gee KR, Agnew BJ and
Clarke ST: Detection of S-phase cell cycle progression using
5-ethynyl-2′-deoxyuridine incorporation with click chemistry, an
alternative to using 5-bromo-2′-deoxyuridine antibodies.
Biotechniques. 44:927–929. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsu YC and Fuchs E: A family business:
Stem cell progeny join the niche to regulate homeostasis. Nat Rev
Mol Cell Biol. 13:103–114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ding XW, Wu JH and Jiang CP: ABCG2: A
potential marker of stem cells and novel target in stem cell and
cancer therapy. Life Sci. 86:631–637. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee HE, Kim JH, Kim YJ, Choi SY, Kim SW,
Kang E, Chung IY, Kim IA, Kim EJ, Choi Y, et al: An increase in
cancer stem cell population after primary systemic therapy is a
poor prognostic factor in breast cancer. Br J Cancer.
104:1730–1738. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Butler SJ, Richardson L, Farias N,
Morrison J and Coomber BL: Characterization of cancer stem cell
drug resistance in the human colorectal cancer cell lines HCT116
and SW480. Biochem Biophys Res Commun. 490:29–35. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Trzpis M, McLaughlin PM, de Leij LM and
Harmsen MC: Epithelial cell adhesion molecule: More than a
carcinoma marker and adhesion molecule. Am J Pathol. 171:386–395.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin CW, Liao MY, Lin WW, Wang YP, Lu TY
and Wu HC: Epithelial cell adhesion molecule regulates tumor
initiation and tumorigenesis via activating reprogramming factors
and epithelial-mesenchymal transition gene expression in colon
cancer. J Biol Chem. 287:39449–39459. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Souček K, Gajdušková P, Brázdová M,
Hýzd'alová M, Kocí L, Vydra D, Trojanec R, Pernicová Z, Lentvorská
L, Hajdúch M, et al: Fetal colon cell line FHC exhibits tumorigenic
phenotype, complex karyotype, and TP53 gene mutation. Cancer
Genet Cytogenet. 197:107–116. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Doyle L and Ross DD: Multidrug resistance
mediated by the breast cancer resistance protein BCRP (ABCG2).
Oncogene. 22:7340–7358. 2003. View Article : Google Scholar : PubMed/NCBI
|
